GGrantIndex
Sort

64,565 grants matching drug discovery

Proton-coupled folate/antifolate transport

$484,821
Israel David Goldman · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA

Structure and function of novel prokaryotic DNA transposases

$484,808
Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

NAPS2 Biofluid Core

$484,808
Paul T Kotzbauer · Washington University · U19 · FY2023 · AG

K-Ras sumoylation in cell proliferation and transformation

$484,800
Wei Dai · New York University School Of Medicine · R01 · FY2021 · CA

SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATION

$484,785
Marlene Belfort · State University Of New York At Albany · R01 · FY2014 · GM

SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATION

$484,785
Marlene Belfort · State University Of New York At Albany · R01 · FY2015 · GM

PET Imaging Agent for Diabetes Mellitus

$484,721
Jogesh Mukherjee · University Of California-Irvine · RC1 · FY2009 · DK

Electrical Stimulation of Human Myocytes in Microgravity: An In Vitro Model to Evaluate Therapeutics to Counteract Muscle Wasting

$484,664
Siobhan Malany · University Of Florida · UG3 · FY2019 · TR

Drug Effect Discovery Through Data Mining and Integrative Chemical Biology

$484,645
Nicholas P Tatonetti · Columbia University Health Sciences · R01 · FY2018 · GM

Drug Effect Discovery Through Data Mining and Integrative Chemical Biology

$484,645
Nicholas P Tatonetti · Columbia University Health Sciences · R01 · FY2016 · GM

Drug Effect Discovery Through Data Mining and Integrative Chemical Biology

$484,645
Nicholas P Tatonetti · Columbia University Health Sciences · R01 · FY2017 · GM

Drug Effect Discovery Through Data Mining and Integrative Chemical Biology

$484,645
Nicholas P Tatonetti · Columbia University Health Sciences · R01 · FY2015 · GM

High-throughput screening for NAD+-replenishing neuroprotective compounds

$484,603
Corinne Ida Lasmezas · Scripps Florida · R01 · FY2014 · NS

Regulation of apoptosis by PI 3-kinase/Akt signaling

$484,567
Geoffrey M Cooper · Boston University (Charles River Campus) · R01 · FY2009 · CA

New deubiquitinating enzymes, poly-ubiquitin substrates and assays.

$484,544
Kirsty A Lapan · Boston Biochem, Inc. · R44 · FY2008 · GM

Nicotine delivery to rodent with lung alveolar region-targeted aerosol technology

$484,537
Xinmin Simon Xie · Afasci, Inc. · R44 · FY2014 · DA

New Technologies for Accelerating the Discovery and Characterization of Neuroactives that Address Substance Use Disorders

$484,500
Matthew N McCarroll · University Of California, San Francisco · DP1 · FY2023 · DA

New Technologies for Accelerating the Discovery and Characterization of Neuroactives that Address Substance Use Disorders

$484,500
Matthew N McCarroll · University Of California, San Francisco · DP1 · FY2024 · DA

New Technologies for Accelerating the Discovery and Characterization of Neuroactives that Address Substance Use Disorders

$484,500
Matthew N McCarroll · University Of California, San Francisco · DP1 · FY2025 · DA

Utilizing genetic and functional strategies to identify causal genes and alleles

$484,483
Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2017 · GM

Novel metabolic actions of GIP

$484,456
Jonathan E Campbell · Duke University · R01 · FY2021 · DK

Synthetic Studies on Alkaloids Isolated from Lycopodium annotium and a New Synthesis of Tetrodotoxin

$484,368
Dirk H Trauner · New York University · · FY2019 · MPS

Discovery and development of nociceptin receptor ligands in alcohol dependence

$484,358
Claes Robert Wahlestedt · Scripps Florida · R01 · FY2009 · AA

Core--Drug Design for the Molecular Target MLK-3

$484,353
Harris A Gelbard · University Of Rochester · P01 · FY2007 · MH

New Catalytic Methods for the Synthesis of Complex Molecules

$484,335
David A Nicewicz · Univ Of North Carolina Chapel Hill · R35 · FY2025 · GM